Literature DB >> 361093

Interaction of thiabendazole with fungal tubulin.

L C Davidse, W Flach.   

Abstract

Thiabendazole, 2-(4'-thiazolyl)benzimidazole, at 80 micrometer completely inhibits mitosis in hyphae of Aspergillus nidulans, growing in liquid culture. DNA and RNA synthesis and mycelial growth are only partially inhibited at this concentration. Binding studies with cell-free mycelial extracts from Penicillium expansum showed that thiabendazole competitively inhibits [14C]carbendazim binding to tubulin, which suggests that the antimitotic activity of thiabendazole is based on interference with microtubule assembly. Tubulin from a thiabendazole-resistant and carbendazim-highly sensitive mutant of P. expansum has a lower affinity to thiabendazole and a higher affinity to carbendazim than tubulin from a wide-type strain. This indicates that in this mutant the structure of the binding site is affected. The data presented suggest that several sites of both the tubulin and ligand molecule are involved in the binding of benzimidazole compounds to fungal tubulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361093     DOI: 10.1016/0304-4165(78)90456-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Oriented growth of Blastocladiella emersonii in gradients of ionophores and inhibitors.

Authors:  R L Harold; F M Harold
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

2.  Cell cycle regulators interact with pathways that modulate microtubule stability in Saccharomyces cerevisiae.

Authors:  Aya Shohat-Tal; Dan Eshel
Journal:  Eukaryot Cell       Date:  2011-10-28

3.  Fungal beta-tubulin, expressed as a fusion protein, binds benzimidazole and phenylcarbamate fungicides.

Authors:  D W Hollomon; J A Butters; H Barker; L Hall
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  CDP1, a novel Saccharomyces cerevisiae gene required for proper nuclear division and chromosome segregation.

Authors:  P K Foreman; R W Davis
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

5.  Infection Dynamics of ATG8 in Leishmania: Balancing Autophagy for Therapeutics.

Authors:  Vrushali Guhe; Farah Anjum; Alaa Shafie; Md Imtaiyaz Hassan; Visweswara Rao Pasupuleti; Shailza Singh
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

6.  Discovery of new vascular disrupting agents based on evolutionarily conserved drug action, pesticide resistance mutations, and humanized yeast.

Authors:  Riddhiman K Garge; Hye Ji Cha; Chanjae Lee; Jimmy D Gollihar; Aashiq H Kachroo; John B Wallingford; Edward M Marcotte
Journal:  Genetics       Date:  2021-08-26       Impact factor: 4.402

7.  Meiosis-specific failure of cell cycle progression in fission yeast by mutation of a conserved beta-tubulin residue.

Authors:  Janet L Paluh; Alison N Killilea; H William Detrich; Kenneth H Downing
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

Review 8.  Macrophomina phaseolina : General Characteristics of Pathogenicity and Methods of Control.

Authors:  Nathalie Marquez; María L Giachero; Stéphane Declerck; Daniel A Ducasse
Journal:  Front Plant Sci       Date:  2021-04-22       Impact factor: 5.753

9.  Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent.

Authors:  Hye Ji Cha; Michelle Byrom; Paul E Mead; Andrew D Ellington; John B Wallingford; Edward M Marcotte
Journal:  PLoS Biol       Date:  2012-08-21       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.